GLP Watchdog

Embody vs Hers

Hers has an open FDA warning letter dated September 9, 2025. Embody has none. On compounded semaglutide injection, Embody costs $1,440 less a year at standing rates: $79 a month against $199 a month at Hers.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Embody / Hers

Featured pick (affiliate partner)

Embody logo

Embody

9.3/10

Hers logo

Hers

6.8/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$79/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
All 50 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Embody
Visit Hers

Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, Hers 6.8). How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. Embody has none.

  2. 02

    Embody names four pharmacies. Hers names three pharmacies.

  3. 03

    On compounded semaglutide injection, Embody costs $1,440 less a year at standing rates: $79 a month against $199 a month at Hers.

  4. 04

    Only Embody lists a price for compounded tirzepatide injection and compounded oral tirzepatide. Only Hers lists a price for brand-name tirzepatide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Embody

Hers

Compounded semaglutide injection

$79/moLower

$948 a year

$199/mo

$2,388 a year

Compounded tirzepatide injection

$129/mo

$1,548 a year

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Compounded oral tirzepatide

$329/mo

$3,948 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the one-month plan; 3-, 6- and 12-month plans are prepaid
None
Refunds
No refunds once paid; a partial refund only after a medical disqualification
No refund guaranteed once the pharmacy has processed an order
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Embody: October 30, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Embody

9.3/10
Featured pick (affiliate partner)
  • No FDA warning letter on record
  • $1,440 a year less on compounded semaglutide injection
  • Sells compounded tirzepatide injection and compounded oral tirzepatide, which Hers does not price
  • Price includes clinician visits
Visit Embody

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which Embody does not price
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

Scores

Embody 9.3 · Hers 6.8 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
7.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Embody vs Hers: questions

Hers has an open FDA warning letter dated September 9, 2025. Embody has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Embody names four pharmacies. Hers names three pharmacies. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Embody, by $1,440 a year at standing rates. Embody: $79 a month, about $948 a year. Hers: $199 a month, about $2,388 a year.
Embody states you can cancel at any time; refunds: no refunds once paid; a partial refund only after a medical disqualification. Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order.
Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, Hers 6.8).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks